• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

仅含孕激素的口服避孕药的安全性和有效性问题——流行病学视角

The safety and efficacy issues of progestin-only oral contraceptives--an epidemiologic perspective.

作者信息

Chi I

机构信息

Family Health International, Research Triangle Park, North Carolina 27709.

出版信息

Contraception. 1993 Jan;47(1):1-21. doi: 10.1016/0010-7824(93)90105-g.

DOI:10.1016/0010-7824(93)90105-g
PMID:8435997
Abstract

Progestogen-only oral contraceptives (POCs) are generally considered a good contraceptive choice for brestfeeding women and for women who want to use an oral form of contraception, but are not suited for, or cannot tolerate the side effects of, estrogen-containing preparations. However, a number of POCs' safety, efficacy and other related issues remain to be addressed. This paper reviews recent literature and evaluates these issues from an epidemiologic perspective. The small number of users imposes severe limitations in designing epidemiologic studies to address POCs' long-term safety issues, but available information suggests POCs are at least as safe as, if not safer than, COCs. Compared to COCs, POCs are more likely to cause menstrual disturbances which, in turn, could affect their acceptability and lead to poor compliance and hence higher pregnancy rates. POCs' efficacy has been estimated to be between 1.4 and 4.3 pregnancies per 100 woman-years of use. Lower pregnancy rates approaching those of COCs have been reported in centers with good counseling. POCs' benefits outweigh their risks. However, more studies are needed to further address POCs' safety and efficacy issues.

摘要

仅含孕激素的口服避孕药(POCs)通常被认为是哺乳期女性以及希望采用口服避孕方式但不适合或无法耐受含雌激素制剂副作用的女性的良好避孕选择。然而,一些POCs的安全性、有效性及其他相关问题仍有待解决。本文回顾了近期文献,并从流行病学角度评估了这些问题。使用者数量较少给设计解决POCs长期安全性问题的流行病学研究带来了严重限制,但现有信息表明POCs至少与复方口服避孕药(COCs)一样安全,甚至可能更安全。与COCs相比,POCs更易引起月经紊乱,这反过来可能影响其可接受性,并导致依从性差,从而使妊娠率升高。据估计,POCs的有效性为每100名女性每年有1.4至4.3次妊娠。在提供良好咨询服务的中心,已报告妊娠率较低,接近COCs的妊娠率。POCs的益处大于风险。然而,需要更多研究来进一步解决POCs的安全性和有效性问题。

相似文献

1
The safety and efficacy issues of progestin-only oral contraceptives--an epidemiologic perspective.仅含孕激素的口服避孕药的安全性和有效性问题——流行病学视角
Contraception. 1993 Jan;47(1):1-21. doi: 10.1016/0010-7824(93)90105-g.
2
Progestin-only oral contraception: a comprehensive review.仅含孕激素的口服避孕药:全面综述
Contraception. 1994 Dec;50(6 Suppl 1):S1-195.
3
Exogenous progestins and breast cancer.外源性孕激素与乳腺癌
Epidemiol Rev. 1993;15(1):98-107. doi: 10.1093/oxfordjournals.epirev.a036120.
4
The progestogen-only mini-pill.仅含孕激素的短效口服避孕药。
Contraception. 1982 Oct;26(4):373-88. doi: 10.1016/0010-7824(82)90104-4.
5
Contraceptive Steroids, age, and the cardiovascular system.避孕类固醇、年龄与心血管系统
Am J Obstet Gynecol. 1982 Mar 15;142(6 Pt 2):747-51. doi: 10.1016/s0002-9378(16)32482-6.
6
A multicenter clinical trial of a progestin-only oral contraceptive in lactating women.
Contraception. 1993 Jan;47(1):23-35. doi: 10.1016/0010-7824(93)90106-h.
7
Noncontraceptive health benefits of oral steroidal contraceptives.口服甾体避孕药的非避孕健康益处。
Am J Obstet Gynecol. 1982 Mar 15;142(6 Pt 2):809-16. doi: 10.1016/s0002-9378(16)32492-9.
8
Progestogens in cardiovascular diseases: an introduction to the epidemiologic data.心血管疾病中的孕激素:流行病学数据介绍
Am J Obstet Gynecol. 1982 Mar 15;142(6 Pt 2):752-7. doi: 10.1016/s0002-9378(16)32483-8.
9
Combined oral contraceptives: acceptability and effective use.复方口服避孕药:可接受性与有效使用
Br Med Bull. 1993 Jan;49(1):140-57. doi: 10.1093/oxfordjournals.bmb.a072593.
10
The combined oral contraceptive. Risks and adverse effects in perspective.复方口服避孕药。风险与不良反应概述。
Drug Saf. 1995 Feb;12(2):91-6. doi: 10.2165/00002018-199512020-00002.

引用本文的文献

1
The effect of protease inhibitors on the cervical mucus of HIV-positive women taking norethindrone contraception.蛋白酶抑制剂对服用炔诺酮避孕的HIV阳性女性宫颈黏液的影响。
Eur J Contracept Reprod Health Care. 2015 Apr;20(2):149-53. doi: 10.3109/13625187.2014.957826. Epub 2014 Oct 6.
2
Managing women with gestational diabetes mellitus in the postnatal period.产后管理妊娠糖尿病妇女。
Diabetes Obes Metab. 2010 Jan;12(1):20-5. doi: 10.1111/j.1463-1326.2009.01147.x. Epub 2009 Sep 25.